ICDwise
D3A ⚠ Non-billable

Benign neuroendocrine tumors

ICD-10-CM · FY2026 · Neoplasms

Code
D3A
System
ICD-10-CM
Billable
No — use specific code
Effective
FY2026
Chapter
Neoplasms
Source
CMS / CDC NCHS
⚠ Verify before billing. Confirm against the current CMS/NCHS ICD-10-CM files and your payer's rules before claims submission.

Official coding notes

From CMS's ICD-10-CM Tabular List.

Excludes2 — not included here, but may code together
  • benign pancreatic islet cell tumors (D13.7)
Use additional code
  • code to identify any associated endocrine syndrome, such as:
  • carcinoid syndrome (E34.00)
Code also
  • any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Frequently asked questions

What is ICD-10 code D3A?
ICD-10-CM code D3A represents Benign neuroendocrine tumors. It is a non-billable header code requiring a more specific subcategory in the Neoplasms chapter, effective October 1, 2025 – September 30, 2026.
Is D3A billable?
No. D3A is a non-billable header. Select a more specific subcategory for claims submission.
What chapter is D3A in?
D3A belongs to the Neoplasms chapter (C00–D49) of ICD-10-CM.

Related codes in the D3A category

Search all 98,186 ICD-10-CM codes instantly

Search ICDwise →